Radicava (edaravone)

Home / Radicava (edaravone)


Radicava™ (edaravone) is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) to treat people with amyotrophic lateral sclerosis (ALS).

Optimed Infusion is a private infusion suite in Columbus Ohio and been selected by Mitsubishi Tanabe Pharma to infuse Radicava

For more information, click on the links below:

     ALS Association– Frequently Asked Questions About Radicava
     ALS Biomarkers Study
     FDA approves drug to treat ALSImage result for Radicava




All the fields are required